Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2012

Novavax, Inc. (NVAX) to Present at the ROTH Capital Partners 24th Annual Conference

Novavax is a global clinical-stage biopharmaceutical company engaged in creating novel vaccines to address a wide range of infectious diseases throughout the world. Using innovative technology and new efficient manufacturing approaches, Novavax produces potent vaccine candidates with the goal of … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Numerex Corp. (NMRX) to Present at the ROTH Capital Partners 24th Annual Conference

Numerex is a leading global provider of machine-to-machine (M2M) business services, technology, and products used to develop and support M2M solutions for enterprise and government markets throughout the world. The company offers Numerex DNA, which includes hardware and smart devices, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Nuvo Research, Inc. (NRI) to Present at the ROTH Capital Partners 24th Annual Conference

Nuvo Research is a specialty pharmaceutical company engaged in building a portfolio of products for the topical treatment of pain. Through its Germany-based subsidiary, Nuvo Research GmbH, the company is additionally developing the compound WF10, an immune modulating drug candidate … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

NVIDIA Corp. (NVDA) to Present at the ROTH Capital Partners 24th Annual Conference

NVIDIA invented the GPU in 1999 and awakened the world to computer graphics. GPUs are now utilized by PC gamers, professionals, and researchers across the globe. NVIDIA’s processors power a wide variety of products ranging from smartphones to supercomputers, and … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Obagi Medical Products, Inc. (OMPI) to Present at the ROTH Capital Partners 24th Annual Conference

Obagi Medical Products is a specialty pharmaceutical company and a leading provider of proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. The company’s products utilize its Penetrating Therapeutics technologies to improve the penetration of agents … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Ocean Power Technologies, Inc. (OPTT) to Present at the ROTH Capital Partners 24th Annual Conference

Ocean Power Technologies is a pioneering wave-energy technology company. OPT generates reliable, clean, and environmentally beneficial electricity by harnessing ocean wave resources. The company has a solid track record in the advancement of wave energy and participates in an estimated … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

On Assignment, Inc. (ASGN) to Present at the ROTH Capital Partners 24th Annual Conference

On Assignment is a leading global provider of diversified professional staffing solutions. The company supplies quality, highly skilled, hard-to-find professionals for temporary, contract-to-hire, and direct hire assignments in the life sciences, healthcare, and technology sectors. On Assignment’s professionals surpass merely … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

OncoSec Medical, Inc. (ONCS) to Present at the ROTH Capital Partners 24th Annual Conference

OncoSec Medical is a biopharmaceutical company engaged in developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies for the treatment of solid tumor cancers and metastatic disease. Addressing an unmet medical need, OMS ElectroOncology therapies represent a potential solution for … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Onyx Pharmaceuticals, Inc. (ONXX) to Present at the ROTH Capital Partners 24th Annual Conference

Onyx Pharmaceuticals is a worldwide pharmaceutical company that is engaged in the development and the commercialization of innovative therapies for improving the lives of cancer patients and sufferers of other serious diseases. The company’s focus is on developing novel medicines … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Oragenics, Inc. (ORNI) to Present at the ROTH Capital Partners 24th Annual Conference

Oragenics is a leading nutraceutical company based in Florida. The company’s focus is on oral care products for humans and companion animals, and its proprietary products are Evora and ProBiora3. Both products are presently sold in the U.S. and also … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment